1246203-32-6

1246203-32-6 structure
1246203-32-6 structure

Name N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide
Synonyms Ethanesulfonamide, N-[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)-
N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}-2-(dimethylamino)ethanesulfonamide
N-(4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}phenyl)-2-(dimethylamino)ethanesulfonamide
N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-2-(dimethylamino)ethanesulfonamide
Density 1.5±0.1 g/cm3
Boiling Point 769.9±70.0 °C at 760 mmHg
Molecular Formula C26H30F2N8O4S
Molecular Weight 588.629
Flash Point 419.4±35.7 °C
Exact Mass 588.207886
PSA 135.98000
LogP 2.44
Vapour Pressure 0.0±2.6 mmHg at 25°C
Index of Refraction 1.664

~%

1246203-32-6 structure

1246203-32-6

Literature: Pathway Therapeutics Limited Patent: US2010/249099 A1, 2010 ; Location in patent: Page/Page column 83 ; US 20100249099 A1
Precursor  2

DownStream  1

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.